Sinol Nasal Sprays Are: Supported by Clinical Data, FDA Registered & Recommended by Physicians

Sinol USA has just completed a prospective, randomized, cross-over study of Sinol in patients with allergic rhinitis. Results of the study showed that patients treated with Sinol had significantly improved symptoms such as runny nose, stuffy nose, itchy nose and sneezing, compared to patients that did not receive any treatment. This study also documented the excellent tolerability of Sinol.
The initial study results will be presented at a major medical meeting early in 2009. An abstract of the results will be posted to this site after the initial dissemination. Full publication of the data in a prestigious peer-reviewed medical journal will follow.

Warning: Not recommended for children under 12. If you are pregnant or nursing, ask a healthcare professional before use.